Growth Metrics

Enanta Pharmaceuticals (ENTA) EBIT Margin Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 530.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,211.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,993.00
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 15,263.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15,263.00
Dec 31, 2025 6,680.00
Sep 30, 2025 1,157.00
Jun 30, 2025 6,389.00
Mar 31, 2025 1,652.00
Dec 31, 2024 -2,884.00
Sep 30, 2024 -6,132.00
Jun 30, 2024 2,195.00
Mar 31, 2024 -4,460.00
Dec 31, 2023 -15,503.00
Sep 30, 2023 -8,019.00
Jun 30, 2023 -7,182.00
Mar 31, 2023 -17,870.00
Dec 31, 2022 -15,174.00
Sep 30, 2022 -14,566.00
Jun 30, 2022 -17,552.00
Mar 31, 2022 -17,755.00
Dec 31, 2021 -14,985.00
Sep 30, 2021 -19,433.00
Jun 30, 2021 -19,606.00
Mar 31, 2021 -18,580.00
Dec 31, 2020 -7,647.00
Sep 30, 2020 -15,523.00
Jun 30, 2020 5,229.00
Mar 31, 2020 6,311.00
Dec 31, 2019 9,212.00
Sep 30, 2019 3,667.00
Jun 30, 2019 1,625.00
Mar 31, 2019 105.00
Dec 31, 2018 -3,361.00
Sep 30, 2018 2,578.00
Jun 30, 2018 2,486.00
Mar 31, 2018 -4,638.00
Dec 31, 2017 -5,287.00
Sep 30, 2017 27,348.00
Jun 30, 2017 -25,778.00
Mar 31, 2017 13,126.00
Dec 31, 2016 54,345.00
Sep 30, 2016 32,435.00
Jun 30, 2016 24,557.00
Mar 31, 2016 33,019.00
Dec 31, 2015 -517.00
Sep 30, 2015 24,594.00
Jun 30, 2015 15,347.00
Mar 31, 2015 -313.00